Search - tctmd.com

Displaying 441 - 460 of 4998

Sort: Relevancy | Date

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Presenter: Simon R. Dixon, Holger Thiele, Jerry D Estep

October 31, 2016

Presentation TCT 2016

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: An Early Career Perspective - A Dedicated Fellowship Is Necessary for New Trainees to Get Into the CHIP Space!

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert F. Riley

October 31, 2016

Presentation TCT 2016

Assessment and Implications of Vasomotion: Implications for BRS

Presenter: Elazer R. Edelman, Juan F. Granada, Habib Samady

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies III? ERACI IV

Presenter: Seung-Jung Park, Leif Thuesen, Alfredo E. Rodriguez

October 31, 2016

Presentation TCT 2016

What Is a CTO Skill Set? Why Is It Different and How Do You Build It?

Presenter: James C. Spratt, Simon J. Walsh, Ashish Pershad

October 31, 2016

Presentation TCT 2016

Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only?

Presenter: Ran Kornowski, Michel R. Le May, Henning Kelbæk

October 31, 2016

Presentation TCT 2016

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: A Mid-Career Perspective - On-the-job Training With Proctoring Is the Most Reliable Method!

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Presenter: Simon R. Dixon, Holger Thiele, Susan M Joseph

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies II? ESTROFA-LM

Presenter: Seung-Jung Park, Leif Thuesen, Jose M. de la Torre Hernandez

October 31, 2016

Presentation TCT 2016

Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion, Recoil, Side Branches, and More

Presenter: Elazer R. Edelman, Juan F. Granada, Richard J. Rapoza

October 31, 2016

Presentation TCT 2016

Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them?

Presenter: Ran Kornowski, Michel R. Le May, Jose P.S. Henriques

October 31, 2016

Presentation TCT 2016

ABSORB III Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Ron Waksman

October 31, 2016

Presentation TCT 2016

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert W. Yeh

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies I? French and LEMAX Registries

Presenter: Seung-Jung Park, Leif Thuesen, Philippe Garot

October 31, 2016

Presentation TCT 2016

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing II: Biomechanical Perspectives

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis

October 31, 2016

Presentation TCT 2016

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses

October 31, 2016

Presentation TCT 2016

Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection and Technique to Optimize Outcomes

Presenter: Seung-Jung Park, Leif Thuesen

October 31, 2016

Presentation TCT 2016

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing I: Pathologic Perspectives

Presenter: Elazer R. Edelman, Juan F. Granada, Renu Virmani

October 31, 2016

Presentation TCT 2016

Why I Became a CTO Operator and What It Means to Me

Presenter: James C. Spratt, Simon J. Walsh, Nicholas J. Lembo

October 31, 2016

Advertisement

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: An Early Career Perspective - A Dedicated Fellowship Is Necessary for New Trainees to Get Into the CHIP Space!

Assessment and Implications of Vasomotion: Implications for BRS

What Have We Learned From Contemporary Left Main Observational Studies III? ERACI IV

What Is a CTO Skill Set? Why Is It Different and How Do You Build It?

Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only?

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: A Mid-Career Perspective - On-the-job Training With Proctoring Is the Most Reliable Method!

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

What Have We Learned From Contemporary Left Main Observational Studies II? ESTROFA-LM

Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion, Recoil, Side Branches, and More

Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them?

ABSORB III Critique: Pros and Cons

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

What Have We Learned From Contemporary Left Main Observational Studies I? French and LEMAX Registries

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing II: Biomechanical Perspectives

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection and Technique to Optimize Outcomes

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing I: Pathologic Perspectives

Why I Became a CTO Operator and What It Means to Me

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content